Endo International plc announces that data regarding the evaluation and rating of cellulite severity will be presented at the Annual Meeting of the American Society for Dermatologic Surgery (ASDS) in Phoenix.
Two posters will be on display October 11th – October 13th: the first, an analysis of the Clinician Reported Photonumeric Cellulite Severity Scale (CR-PCSS) for evaluating cellulite severity; and the second, an analysis of the potential impact of the gender of a healthcare provider (HCP) on rating cellulite severity.
One of the two abstract posters to be presented is titled “Assessing Cellulite Severity: Test-Retest Reliability of and Concordance between New Clinician Reported and Patient Reported Photonumeric Scales” and covers the 5-point photonumeric scales that measure cellulite severity according to the number and depth of dimples on the evaluated area. Results indicate that the CR-PCSS is a reliable tool for evaluating cellulite severity of the buttocks and thighs and correlates well with the Patient Reported Photonumeric Cellulite Severity Scale. This data was previously presented at the 2018 International Society for Pharmacoeconomics and Outcomes Research meeting.
The second abstract poster, titled “Analysis of Potential Impact of Healthcare Provider Gender on Rating Cellulite Severity,” evaluates the influence of gender on healthcare providers’ perception of cellulite severity. The HCPs rated female cellulite severity by viewing a set of digital images that represented the range of cellulite severity on buttocks or thighs. The results indicate that the gender of a HCP does not appear to impact assessment of cellulite severity ratings.
“We are pleased that the data from these studies will be presented at the premier meeting for dermatologic surgeons,” says Matthew Davis, MD, RPh, chief medical officer, senior vice president, research and development, branded pharmaceuticals of Endo Pharmaceuticals, in a media release from the Malvern, Pa-based company.
“It is important that healthcare providers and their patients have a reliable tool for evaluating cellulite severity. We believe the 5-point photonumeric scales enable patients and the clinician treating their cellulite to be aligned during both the informed consent process prior to treatment, and post treatment when they are evaluating the outcomes.”
[Endo International plc]